Table 1 (abstract P222). See text for description
From: Proceedings of the 27th European Paediatric Rheumatology Congress (PReS 2021)
| Â | Sex/age | Time to IFN-score eval. (m) | IFN- score | aCAT (activity/damage) | CMAS | CS (mg/kg) |
|---|---|---|---|---|---|---|
1 | m/10y3m | 45 | 1.98 | 1/1 | - | 0,2 |
2 | f/6y7m | 10 | 33.75 | 6/0 | 45 | 0,7 |
3 | f/5y3m | 21 | 10.8 | 6/1 | - | 1 |
4 | m/13y4m | 93 | 15.52 | 3/1 | 34 | 0 |
5 | m/4y10m | 3 | 11.62 | 2/0 | - | 0 |
6 | f/8y9m | 3 | 44.57 | 9/0 | 10 | 0 |
7 | m/16y1m | 22 | 27.72 | 2/1 | 46 | 0 |
8 | f/3y5m | 16 | 1.26 | 0/1 | 4 | 0,85 |
9 | f/10y10m | 56 | 3.45 | 2/0 | - | 0,1 |
10 | f/ 10y8m | 51 | 1.54 | 0/1 | 48 | 0 |
11 | f/9y6m | 28 | 1.67 | 0/1 | 46 | 0,1 |
12 | f/ 6y2m | 8 | 3.13 | 3/0 | 38 | 1,1 |
13 | f/7y10m | 3 | 2.53 | 5/0 | 18 | 1 |
14 | f/3y6m | 4 | 8.88 | 5/0 | 17 | 0 |
15 | m/9y4m | 36 | 15.06 | 3/0 | 34 | 0 |